fda and compounded glp 1 Compound versions of GLP-1 drugs for weight loss halted by A $49 "Compounded GLP‑1" Sparks

The research protocol should be reviewed and dose reduction or timing adjustment considered

Doctors increasingly see obesity as a chronic condition that needs sustained treatment

This skin condition is not dangerous but is often considered to interfere body's appearance

Impact for Industry Simplifies study design for suitable MR products Aligns Canada with global ICH regions Reduces regulatory gaps between IR and MR BE evaluations Ensures consistency across submissions (especially for global filings) #HealthCanada #ICHM13A #Bioequivalence #ModifiedRelease #Pharma #RegulatoryAffairs #DrugDevelopment #ClinicalResearch #PKStudies #PharmaceuticalIndustry To view or add a comment, sign in Africas Insulin Revolution: Nigeria Joins Egypt & South Africa #Nigeria has signed a landmark deal with Shanghai Haiqiu Industry Co., Ltd